A-Alpha Bio
PrivateLast Round
Grant
May 21, 2024
Total Funding Raised
$65.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
A-Alpha Bio is a biotechnology company that combines synthetic biology and machine learning to analyze protein-protein interactions for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
A-Alpha Bio Comparables
Compare A-Alpha Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepSeq.AI, Inc. | 82% | |
| Aikium | 81% | |
| BigHat Biosciences | 81% |
A-Alpha Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 21, 2024 | ||||
| Series A Extension | Jul 25, 2023 | ||||
| Grant | May 17, 2023 | ||||
| Grant | Mar 1, 2022 | ||||
| Series A | Sep 8, 2021 | ||||
Grant | Sep 1, 2020 |
Key People
Founding team and executive leadership
A-Alpha Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Series A |
| Perceptive Advisors | Series A, Series A Extension |
| United States Department of Defense | Grant |
| Xontogeny | Series A |
| Boom Capital | Seed |
| Lux Capital | Series A |
| Social Capital | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 82% MoM, reaching 8.1K.
- Feb 3, 2026
Partnered with Novo Nordisk to enhance drug discovery using its AI platform.
Recent news
Latest coverage and updates
- partners_withJul 28, 2026
A-Alpha Bio, Inc. partnered with Cradle on Jul 28th '26.
- partners_withJul 28, 2026
A-Alpha Bio, Inc. partnered with GlaxoSmithKline plc on Jul 28th '26.
- launchesJul 7, 2026
A-Alpha Bio, Inc. launched Atlas on Jul 7th '26.
A-Alpha Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about A-Alpha Bio's valuation, stock price, and market status.
Is A-Alpha Bio a public or private company?
A-Alpha Bio is a private company.
What is the current stock price of A-Alpha Bio?
A-Alpha Bio is a private company with no public stock price. No recent secondary market data is available.
How much is A-Alpha Bio worth (valuation)?
Valuation information for A-Alpha Bio is not publicly available.
Can I buy A-Alpha Bio stock?
A-Alpha Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was A-Alpha Bio's last funding round?
A-Alpha Bio's most recent funding round was Grant on May 21, 2024.
Who are the main investors in A-Alpha Bio?
Key investors in A-Alpha Bio include Perceptive Advisors, Madrona Venture Group, OS Fund.
Will A-Alpha Bio IPO soon?
No public IPO plans have been announced for A-Alpha Bio.
How can I track A-Alpha Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor A-Alpha Bio's secondary market activity and sign up for updates.